Samuel Waxman Cancer Research Foundation 25th Annual Collaborating for a Cure Gala…

Samuel Waxman Cancer Research Foundation 25th Annual Collaborating for a Cure Gala…


Honoring Two Giants in the Fight Against Cancer- Samuel Waxman, M.D. Chief Executive Officer and Founder, and Michael Nierenberg, Chairman of the Board, Samuel Waxman Cancer Research Foundation (SWCRF)

The 25th Annual Collaborating for a Cure Gala, one of New York City’s favorite charity events celebrated its silver anniversary at Cipriani Wall Street. The “fun-raiser as opposed to fundraiser” as described by Michael Nierenberg raised more than $6 million towards the goal of funding the next five years of crucial SWCRF cancer research programs such as the Partnership for Aging and Cancer Research Program, the SWCRF Institute Without WallsTM, and the Women’s Cancer Research Program.

Following a cocktail reception across the street, guests made their way to the main dining room where emcee, CBS’s Chris Wragge, welcomed the more than 700 guests, introduced the evening’s honorees, and highlighted many of the Foundation’s groundbreaking achievements over the past 50 years. “Tonight, we have a great program to celebrate two giants in the fight against cancer”, said Wragge.

Upon receiving the Vision and Leadership Award, SWCRF Board Chairman Michael Nierenberg commented, “The real honorees are Dr. Waxman and the great heroes like him who treat and cure cancer every day.”

Founder and CEO Dr. Samuel Waxman, who received the well-deserved and long-overdue Lifetime Achievement Award, spoke to his vision (goal) for a future in which cancer does not have to be a disease associated with aging. “The incidence of cancer is increasing, in part, as a by-product of improvements we are making in human longevity,” said Dr. Waxman. “But through our collaborative research programs, we can flatten this curve. I am thrilled to be a part of many amazing breakthroughs that have occurred in cancer research – with more to come.”

Special guest, author and breast cancer survivor, Musa Mayer, shared why she has been a longtime supporter of SWCRF and very generously offered a $1 million match for all donations made during the gala. “I will be celebrating my 80th birthday soon thanks to the work of this foundation and Dr. Samuel Waxman,” said Mayer.

As in previous years, the Collaborating for a Cure Gala included a live auction during the night’s festivities, including a meet and greet with MT. JOY, culinary experiences at the Cipriani Vault, il Buco Vita, and New York Vintners, and a Palm Bay Italian Winery experience (in Tuscany) to name a few. There was also a raffle for a private 7-day Bahamas cruise aboard an 82-foot, hybrid-powered, luxury yacht.

Notable attendees include SWCRF Board Chairman Michael Nierenberg, Founder and CEO Dr. Samuel Waxman, Gala Event Chairs, Spencer Waxman, Nicholas Santoro, Baron Silverstein, Marc Taub and Gala MC, Chris Wragge, Elin Nierenberg, Marion Waxman, Sandra Dugoff, Julie Waxman, Eliz Waxman, Jack Waxman, Sophia Bergan, Mario Pecoraro, Chris Arlotta, Mark D. Friedman, Jeremy Hoffman, Sara Waxman, Bettina Waxman, Scott Waxman, Bryan Griffin, Katya Tolstova, Nadja Sayej, William T. Sullivan, Erica Fineberg. Robin Lathrop, MT. JOY.

Known for its history of top-notch live performances, this year’s gala featured a live concert by MT. JOY.

For more information, visit www.waxmancancer.org/gala.

For selected high-resolutions images, visit: https://bit.ly/3XbltYB

(Photo credits: Jared Siskin PMC/Getty Images)

To view the Full Gallery of Images (Patrick McMullen): https://bit.ly/3OfqN9r

To view the Full Gallery of Images (Getty Images): https://bit.ly/3OikJwC

About The Samuel Waxman Cancer Research Foundation (SWCRF):

The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $100 million to support the work of more than 200 researchers across the globe. For more information about the SWCRF research, visit www.waxmancancer.org.

Facebook: WaxmanCancer https://www.facebook.com/WaxmanCancer

Instagram: @waxmancancer https://www.instagram.com/waxmancancer/

Twitter: @waxmancancer https://twitter.com/WaxmanCancer

PRESS CONTACT (SWCRF):

Norah Lawlor | Lawlor Media Group | www.lawlormediagroup.com

Norah@lawlormediagroup.com | Tel: (212) 967-6900

I: lawlormedia | T: @LawlorMedia | F: LawlorMediaGroup

Samuel Waxman, M.D., Marion Waxman (Photo Credit: Jared Siskin PMC/Getty Images)

Chris Wragge, Michael Nierenberg (Photo Credit: Jared Siskin PMC/Getty Images)

Gala MC Chris Wragge (Photo Credit: Jared Siskin PMC/Getty Images)

Bryan Griffin (Photo Credit: Jared Siskin PMC/Getty Images)

Katya Tolstova (Photo Credit: Jared Siskin PMC/Getty Images)

Nadja Sayej (Photo Credit: Jared Siskin PMC/Getty Images)

Lawlor Media Group, inc.

434 West 33rd Street

7th Floor

New York, NY

10001

United States of America

T: 212.967.6900 C: 917.774.1000

www.lawlormediagroup.com

This message is confidential. It may also be privileged or otherwise protected by work product immunity or other legal rules. If you have received it by mistake, please let us know by e-mail reply and delete it from your system; you may not copy this message or disclose its contents to anyone. The integrity and security of this message cannot be guaranteed on the Internet.

#samwaxman #samuelwaxman #cancer #curegala #newyorkcity #ny #nyc #samuelwaxmancancerresearchfoundation #swcrf #cipriani #wallstreet

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *